Abstract
REM sleep behavior disorder (RBD) is the strongest prodromal marker for α-synucleinopathies. The Horvath DNA-methylation-age (DNAm-age) is an epigenetic clock reflecting biological aging. We found an association of DNAm-age-acceleration with RBD age-at-onset at baseline (N=162; B=-0.68; SE=0.12; P=2.59e-08) and follow-up (N=45; B=-1.07; SE=0.21; P=9.73e-06). The result remains similar after accounting for genetic risk-factors (e.g., RBD polygenic risk score). On average, RBD patients with faster vs slow/normal epigenetic aging had a 5.2-year earlier phenoconversion, and the cox-regression analysis revealed a trend towards significance (N=53; HR=1.05 (0.99-1.11); P=0.06). Our findings suggest that DNAm-age-acceleration is a potential biomarker for earlier RBD onset. This article is protected by copyright. All rights reserved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
